Glial fibrillary acidic protein promoter (GFAP promoter) (GFAP promoter)

The Glial fibrillary acidic protein (GFAP) promoter is a DNA regulatory sequence that controls the expression of GFAP, the hallmark intermediate filament protein of mature astrocytes in the central nervous system (Brenner et al., 1994, Journal of Neuroscience). In biotechnology, specific segments of this promoter, such as the gfa2 fragment, are widely employed in viral vectors to achieve astrocyte-specific delivery of gene therapies, optogenetic tools, and calcium indicators (Morelli et al., 1999, Gene Therapy). While not a traditional protein target for small molecules, the promoter is a critical focus in Alexander disease, where gain-of-function mutations in the GFAP gene lead to toxic protein aggregation; here, therapeutic strategies aim to suppress promoter activity or degrade the resulting mRNA (Messing, 2018, Genetics in Medicine). The promoter's activity is highly upregulated during reactive gliosis, a process associated with neuroinflammation, stroke, and neurodegenerative diseases like Alzheimer's and ALS (Eng et al., 2000, Neurochemical Research). Consequently, the GFAP promoter is both a vital tool for cell-type-specific targeting and a key regulatory element in the pathogenesis of various neurological disorders (Hagemann et al., 2018, Science Translational Medicine).

Other names

gfa2 promoterGFAP regulatory elementAstrocyte-specific promoter

The GFAP promoter serves as a cis-regulatory element used in gene therapy to drive astrocyte-specific expression of therapeutic payloads, or it is targeted for transcriptional downregulation to treat GFAP-overexpression disorders.